| (+)-15-epi Cloprostenol |
|
|
|
|
|
|
|
| (+)-Cloprostenol sodium |
|
|
|
|
|
|
|
| (+)-Fluprostenol |
|
|
|
|
|
|
|
| (+)-Fluprostenol-d4 |
|
|
|
|
|
|
|
| (+)-JJ-450 |
|
|
|
|
|
|
|
| (+)-Oxypeucedanin methanolate |
|
|
|
|
|
|
|
| (+)-Cloprostenol |
|
|
|
|
|
|
98.06% |
| (15R)-Bimatoprost |
|
|
|
|
|
|
|
| (15S)-15-Methylprostaglandin E2 |
|
|
|
|
|
|
|
| (8-epi)-BW 245C |
|
|
|
|
|
|
|
| (E/Z)-3-Hydroxylicochalcone A |
|
|
|
|
|
|
|
| (E/Z)-Ozagrel sodium |
|
|
|
|
|
|
|
| (R)-L 888607 |
|
|
|
|
|
|
99.69% |
| (R)-Vorbipiprant |
|
|
|
|
|
|
|
| (Rac)-BW 245C |
|
|
|
|
|
|
|
| (Rac)-SC-31391 |
|
|
|
|
|
|
|
| (Rac)-Beraprost |
|
|
|
|
|
|
|
| (S)-AL-8810 |
|
|
|
|
|
|
|
| (S)-Butaprost free acid |
|
|
|
|
|
|
|
| (S)-Trimetoquinol hydrochloride |
|
|
|
|
|
|
|
| (Z)-ONO 1301 |
|
|
|
|
|
|
98.13% |
| (±)12-HEPE |
|
|
|
|
|
|
|
| (±)5-iPF2α-VI |
|
|
|
|
|
|
99.0% |
| 1,2,3-Trilinoelaidoyl glycerol |
|
|
|
|
|
|
98.0% |
| 11-Deoxy prostaglandin E1 |
|
|
|
|
|
|
|
| 11-Deoxy Prostaglandin E2 |
|
|
|
|
|
|
99.0% |
| 11-deoxy Prostaglandin F1α |
|
|
|
|
|
|
|
| 11-Deoxy-11-methylene PGD2 |
|
|
|
|
|
|
|
| 11-Deoxy-16,16-dimethyl-PGE2 |
|
|
|
|
|
|
|
| 11-epi-PGE1 |
|
|
|
|
|
|
|
| 11-keto Fluprostenol |
|
|
|
|
|
|
|
| 11β-Misoprostol |
|
|
|
|
|
|
|
| 11β-Prostaglandin E2 |
|
|
|
|
|
|
99.9% |
| 12(R)-HETE |
|
|
|
|
|
|
99.68% |
| 12(S)-HPEPE |
|
|
|
|
|
|
|
| 12(S)-Hydroxy-16-heptadecynoic acid |
|
|
|
|
|
|
|
| 13(R),14(R)-epoxy Fluprostenol isopropyl ester |
|
|
|
|
|
|
|
| 13,14-Dihydro-15-keto PGF1α |
|
|
|
|
|
|
|
| 13,14-Dihydro-15-keto prostaglandin D2 |
|
|
|
|
|
|
99.90% |
| 13,14-Dihydro-15-keto prostaglandin D2-d9 |
|
|
|
|
|
|
|
| 13,14-Dihydro-15-keto Prostaglandin F2α-d4 |
|
|
|
|
|
|
|
| 13,14-Dihydro-15-keto-tetranor prostaglandin E2 |
|
|
|
|
|
|
|
| 13,14-epoxy Travoprost |
|
|
|
|
|
|
|
| 15(R)-15-Methyl Prostaglandin F2α |
|
|
|
|
|
|
|
| 15(R)-15-Methyl prostaglandin F2α methyl ester |
|
|
|
|
|
|
|
| 15(R)-17-Phenyl trinor Prostaglandin F2α |
|
|
|
|
|
|
|
| 15(R)-Prostaglandin D2 |
|
|
|
|
|
|
99.9% |
| 15(R)-Prostaglandin E2 |
|
|
|
|
|
|
|
| 15(R)-PTA2 |
|
|
|
|
|
|
|
| 15(R)-15-Methyl prostaglandin D2 |
|
|
|
|
|
|
98.0% |
| 15(S)-15-methyl Prostaglandin D2 |
|
|
|
|
|
|
|
| 15(S)-15-Methyl Prostaglandin F2α ethyl amide |
|
|
|
|
|
|
|
| 15(S)-Fluprostenol |
|
|
|
|
|
|
|
| 15(S)-HpEPE |
|
|
|
|
|
|
|
| 15(S)-Latanoprost |
|
|
|
|
|
|
|
| 15-A2t-Isoprostane |
|
|
|
|
|
|
|
| 15-Deoxy-16-hydroxy-16-vinyl-PGE2 Me ester |
|
|
|
|
|
|
|
| 15-Deoxy-Δ12,14-prostaglandin A2 |
|
|
|
|
|
|
|
| 15-deoxy-Δ12,14-Prostaglandin D2 |
|
|
|
|
|
|
98.0% |
| 15-deoxy-Δ12,14-Prostaglandin D2-d4 |
|
|
|
|
|
|
|
| 15-Deoxy-Δ12,14-prostaglandin J2 glutathione |
|
|
|
|
|
|
95% |
| 15-epi Prostaglandin A1 |
|
|
|
|
|
|
|
| 15-Keto Bimatoprost |
|
|
|
|
|
|
|
| 15-Keto latanoprost |
|
|
|
|
|
|
|
| 15-keto-17-phenyl trinor Prostaglandin F2α |
|
|
|
|
|
|
|
| 15-keto-Prostaglandin E2 |
|
|
|
|
|
|
99.0% |
| 15-Methylprostaglandin E1 |
|
|
|
|
|
|
|
| 15-OH Tafluprost |
|
|
|
|
|
|
|
| 15β-Travoprost |
|
|
|
|
|
|
|
| 16(R)-AFP 07 free acid |
|
|
|
|
|
|
|
| 16(R)-Iloprost |
|
|
|
|
|
|
|
| 16(S)-Iloprost |
|
|
|
|
|
|
|
| 16,16-Dimethyl prostaglandin E2 |
|
|
|
|
|
|
99.02% |
| 16,16-Dimethylprostaglandin E1 |
|
|
|
|
|
|
|
| 16,16-Dimethylprostaglandin F2α |
|
|
|
|
|
|
|
| 16,16-Dimethylprostaglandin F2β |
|
|
|
|
|
|
|
| 16-Phenoxy prostaglandin F2α ethyl amide |
|
|
|
|
|
|
|
| 16-Phenoxy tetranor Prostaglandin E2 |
|
|
|
|
|
|
|
| 16-Phenoxy tetranor prostaglandin F2α |
|
|
|
|
|
|
|
| 16-Phenoxy tetranor Prostaglandin F2α methyl amide |
|
|
|
|
|
|
|
| 16-Phenoxy tetranor prostaglandin F2α methyl ester |
|
|
|
|
|
|
|
| 16-Phenyl tetranor Prostaglandin F2α |
|
|
|
|
|
|
|
| 17-Phenoxy trinor prostaglandin F2α |
|
|
|
|
|
|
|
| 17-Phenoxy trinor prostaglandin F2α ethyl amide |
|
|
|
|
|
|
|
| 17-Phenyl trinor PGF2α isopropyl ester |
|
|
|
|
|
|
99.76% |
| 17-Phenyl trinor prostaglandin A2 |
|
|
|
|
|
|
|
| 17-Phenyl trinor prostaglandin E2 ethyl amide |
|
|
|
|
|
|
|
| 17-Phenyl trinor prostaglandin F2α diethyl amide |
|
|
|
|
|
|
|
| 17-Phenyl trinor prostaglandin F2α glycinamide methyl ester |
|
|
|
|
|
|
|
| 17-Phenyl-18,19,20-trinor-PGD2 |
|
|
|
|
|
|
|
| 17-Phenyl-ω-trinor-PGE2 |
|
|
|
|
|
|
99.9% |
| 17-trans Prostaglandin E3 |
|
|
|
|
|
|
|
| 17-trifluoromethylphenyl trinor Prostaglandin F2α |
|
|
|
|
|
|
|
| 17-Trifluoromethylphenyl trinor prostaglandin F2α ethyl amide |
|
|
|
|
|
|
|
| 17-Trifluoromethylphenyl trinor prostaglandin F2α methyl ester |
|
|
|
|
|
|
|
| 17-Trifluoromethylphenyl-13,14-dihydro trinor prostaglandin F1α |
|
|
|
|
|
|
|
| 17-Trifluoromethylphenyl-13,14-dihydro trinor Prostaglandin F2α |
|
|
|
|
|
|
|
| 19(R)-HETE |
|
|
|
|
|
|
98.20% |
| 19(R)-Hydroxy prostaglandin E1 |
|
|
|
|
|
|
|
| 19(R)-hydroxy Prostaglandin E2 |
|
|
|
|
|
|
|
| 19(S)-HETE |
|
|
|
|
|
|
|
| 1a,1b-Dihomo prostaglandin E1 |
|
|
|
|
|
|
|
| 2,3-Dinor thromboxane b1 |
|
|
|
|
|
|
|
| 2,3-Dinor-11beta-prostaglandin F2alpha |
|
|
|
|
|
|
|
| 2-(E-2-decenoylamino)ethyl 2-(cyclohexylethyl) sulfide |
|
|
|
|
|
|
|
| 2-Benzoylthiophene |
|
|
|
|
|
|
|
| 20(R)-Ginsenoside Rh2 |
|
|
|
|
|
|
99.84% |
| 20-Ethyl prostaglandin E2 |
|
|
|
|
|
|
|
| 20-ethyl Prostaglandin F2α |
|
|
|
|
|
|
|
| 20-Hydroxy-PGF2α |
|
|
|
|
|
|
|
| 3-Methoxy prostaglandin F1α |
|
|
|
|
|
|
|
| 4-Ethoxybenzaldehyde |
|
|
|
|
|
|
|
| 4-Oxoetodolac |
|
|
|
|
|
|
|
| 5,6-trans-Bimatoprost |
|
|
|
|
|
|
|
| 5,6-trans-Bimatoprost-d5 |
|
|
|
|
|
|
|
| 5,6-trans-Travoprost |
|
|
|
|
|
|
|
| (+)-5-trans Cloprostenol |
|
|
|
|
|
|
|
| 5-cis Carbaprostacyclin |
|
|
|
|
|
|
|
| 5-cis-15(R)-Iloprost |
|
|
|
|
|
|
|
| 5-trans Prostaglandin D2 |
|
|
|
|
|
|
|
| 5-trans Prostaglandin F2β |
|
|
|
|
|
|
|
| 5-trans-Fluprostenol |
|
|
|
|
|
|
|
| 5R(6S)-EET |
|
|
|
|
|
|
|
| 5S(6R)-EET |
|
|
|
|
|
|
|
| 5-trans-PGE2 |
|
|
|
|
|
|
|
| 6α-Prostaglandin I1 |
|
|
|
|
|
|
|
| 6β-Prostaglandin I1 |
|
|
|
|
|
|
|
| 8-(6,7-Dihydroxy-3,7-dimethyl-2E-octenyloxy)psoralen |
|
|
|
|
|
|
|
| 8-Iso prostaglandin E2 isopropyl ester |
|
|
|
|
|
|
|
| 8-iso Prostaglandin F1β |
|
|
|
|
|
|
|
| 8-iso Prostaglandin F3α |
|
|
|
|
|
|
|
| 8-iso-15-keto Prostaglandin F2α |
|
|
|
|
|
|
|
| 8-Iso-16-cyclohexyl-tetranor prostaglandin E2 |
|
|
|
|
|
|
|
| 8-Isoprostaglandin E2 |
|
|
|
|
|
|
98.31% |
| 8-Isoprostaglandin F2α |
|
|
|
|
|
|
99.9% |
| 9-deoxy-9-methylene Prostaglandin E2 |
|
|
|
|
|
|
|
| 9-keto Fluprostenol |
|
|
|
|
|
|
|
| 9-Keto tafluprost |
|
|
|
|
|
|
|
| 9-Keto Travoprost |
|
|
|
|
|
|
|
| 9-Keto-latanoprost |
|
|
|
|
|
|
|
| AAT-008 |
|
|
|
|
|
|
98.03% |
| ACT-774312 |
|
|
|
|
|
|
|
| AD 4743 |
|
|
|
|
|
|
|
| AFP-07 |
|
|
|
|
|
|
|
| AFP-07 free acid |
|
|
|
|
|
|
|
| Aganepag |
|
|
|
|
|
|
99.71% |
| Aganepag ethanediol |
|
|
|
|
|
|
|
| Aganepag isopropyl |
|
|
|
|
|
|
98.23% |
| AGN 191976 |
|
|
|
|
|
|
|
| AGN 210676 |
|
|
|
|
|
|
|
| AGN 225660 |
|
|
|
|
|
|
|
| AGN192093 |
|
|
|
|
|
|
|
| AH 6809 |
|
|
|
|
|
|
99.57% |
| AH13205 |
|
|
|
|
|
|
|
| AH22921 |
|
|
|
|
|
|
|
| AH23848 hemicalcium salt |
|
|
|
|
|
|
97.0% |
| AL 8810 isopropyl ester |
|
|
|
|
|
|
|
| AL 8810 methyl ester |
|
|
|
|
|
|
|
| AL-12180 |
|
|
|
|
|
|
|
| AL-3138 |
|
|
|
|
|
|
|
| AL-6556 |
|
|
|
|
|
|
|
| AL-6598 |
|
|
|
|
|
|
|
| AL-8810 |
|
|
|
|
|
|
99.0% |
| Alclofenac (lysinate) |
|
|
|
|
|
|
|
| Aligeron |
|
|
|
|
|
|
|
| Alprostadil sodium |
|
|
|
|
|
|
|
| AM-461 |
|
|
|
|
|
|
|
| AM211 |
|
|
|
|
|
|
98.79% |
| AM211 sodium |
|
|
|
|
|
|
|
| AM432 sodium |
|
|
|
|
|
|
|
| AMG-009 |
|
|
|
|
|
|
98.08% |
| Amogastrin |
|
|
|
|
|
|
|
| AMX12006 |
|
|
|
|
|
|
99.9% |
| Anti-MSMP/PSMP Antibody (3D5) |
|
|
|
|
|
|
|
| Apricoxib |
|
|
|
|
|
|
98.84% |
| AR-102 isopropyl ester |
|
|
|
|
|
|
|
| ARRY-502 |
|
|
|
|
|
|
|
| AS604872 |
|
|
|
|
|
|
|
| Asapiprant |
|
|
|
|
|
|
99.89% |
| Ascorbyl tetra-2-hexyldecanoate |
|
|
|
|
|
|
98.0% |
| ASP7657 free base |
|
|
|
|
|
|
99.30% |
| AZ-11665362 |
|
|
|
|
|
|
|
| AZ-1355 |
|
|
|
|
|
|
98.19% |
| AZ12672857 |
|
|
|
|
|
|
98.01% |
| AZD1981 |
|
|
|
|
|
|
99.80% |
| BAY 73-1449 |
|
|
|
|
|
|
98.40% |
| BAY-1316957 |
|
|
|
|
|
|
99.73% |
| BAY-6672 |
|
|
|
|
|
|
|
| BAY-6672 hydrochloride |
|
|
|
|
|
|
98.01% |
| Beraprost-d3 |
|
|
|
|
|
|
|
| BGC-20-1531 |
|
|
|
|
|
|
|
| BGC-20-1531 free base |
|
|
|
|
|
|
95.04% |
| BGC-20-1531 hydrochloride |
|
|
|
|
|
|
|
| BI-671800 |
|
|
|
|
|
|
99.36% |
| Bima SA |
|
|
|
|
|
|
|
| Bimatoprost acid |
|
|
|
|
|
|
99.96% |
| Bimatoprost cyclohexyl amide |
|
|
|
|
|
|
|
| Bimatoprost grenod |
|
|
|
|
|
|
99.10% |
| BM-531 |
|
|
|
|
|
|
|
| BM-573 |
|
|
|
|
|
|
|
| BM567 |
|
|
|
|
|
|
|
| BMY 42393 |
|
|
|
|
|
|
|
| BMY 45778 |
|
|
|
|
|
|
98.98% |
| BPN-37440 |
|
|
|
|
|
|
|
| Butaprost |
|
|
|
|
|
|
99.85% |
| Butaprost free acid |
|
|
|
|
|
|
|
| BW 245C |
|
|
|
|
|
|
99.35% |
| BW A868C |
|
|
|
|
|
|
99.9% |
| Camonagrel |
|
|
|
|
|
|
|
| Carbaprostacyclin methyl ester |
|
|
|
|
|
|
|
| Carbaprostacyclin-biotin |
|
|
|
|
|
|
|
| Carboprost methyl |
|
|
|
|
|
|
|
| Carboprost tromethamine |
|
|
|
|
|
|
99.85% |
| CAY10471 |
|
|
|
|
|
|
99.9% |
| CAY10471 Racemate |
|
|
|
|
|
|
99.00% |
| CAY10509 |
|
|
|
|
|
|
|
| CAY10535 |
|
|
|
|
|
|
|
| CAY10580 |
|
|
|
|
|
|
97.4% |
| CAY10590 |
|
|
|
|
|
|
98.0% |
| CAY10595 |
|
|
|
|
|
|
|
| CCI17464 |
|
|
|
|
|
|
|
| CGS 15435 |
|
|
|
|
|
|
|
| CGS-22652 |
|
|
|
|
|
|
|
| CI-949 |
|
|
|
|
|
|
|
| Cianergoline |
|
|
|
|
|
|
|
| Ciproquazone |
|
|
|
|
|
|
|
| Ciprostene |
|
|
|
|
|
|
|
| Ciprostene calcium |
|
|
|
|
|
|
|
| CJ-42794 |
|
|
|
|
|
|
98.53% |
| Cloprostenol isopropyl ester |
|
|
|
|
|
|
98.0% |
| CP-432 |
|
|
|
|
|
|
|
| Crisdesalazine |
|
|
|
|
|
|
98.92% |
| CRTh2 antagonist 1 |
|
|
|
|
|
|
|
| CRTh2 antagonist 2 |
|
|
|
|
|
|
99.78% |
| CRTh2 antagonist 3 |
|
|
|
|
|
|
|
| CRTh2 antagonist 4 |
|
|
|
|
|
|
|
| CRTH2-IN-1 |
|
|
|
|
|
|
|
| CT-133 |
|
|
|
|
|
|
|
| CV-6504 |
|
|
|
|
|
|
|
| CXT29 |
|
|
|
|
|
|
|
| Cyanidin |
|
|
|
|
|
|
|
| Daltroban |
|
|
|
|
|
|
98.19% |
| Dazmegrel |
|
|
|
|
|
|
|
| DBMB |
|
|
|
|
|
|
|
| Deacetyltanghinin |
|
|
|
|
|
|
|
| DG-041 |
|
|
|
|
|
|
99.61% |
| Diftalone |
|
|
|
|
|
|
|
| Dinoprost (methoxyamine) |
|
|
|
|
|
|
|
| Dinorprostaglandin E1 |
|
|
|
|
|
|
|
| Domitroban |
|
|
|
|
|
|
|
| E 3040 |
|
|
|
|
|
|
|
| E-6700 |
|
|
|
|
|
|
|
| Ebopiprant |
|
|
|
|
|
|
98.65% |
| Ebopiprant hydrochloride |
|
|
|
|
|
|
|
| Ecraprost |
|
|
|
|
|
|
|
| EIPA |
|
|
|
|
|
|
99.73% |
| EIPA hydrochloride |
|
|
|
|
|
|
98.01% |
| Endothelin 1 (swine, human), Alexa Fluor 488-labeled |
|
|
|
|
|
|
|
| Enprostil |
|
|
|
|
|
|
|
| ent-8-iso Prostaglandin F2α |
|
|
|
|
|
|
|
| ent-Prostaglandin E2 |
|
|
|
|
|
|
|
| EP1 receptor antagonist-1 |
|
|
|
|
|
|
|
| EP1-antagonist-1 |
|
|
|
|
|
|
98.60% |
| EP2 receptor agonist 2 |
|
|
|
|
|
|
|
| EP2 receptor agonist 4 |
|
|
|
|
|
|
|
| EP2 receptor antagonist-1 |
|
|
|
|
|
|
99.84% |
| EP2 receptor antagonist-2 |
|
|
|
|
|
|
99.32% |
| EP2 receptor antagonist-3 |
|
|
|
|
|
|
99.08% |
| EP3 antagonist 2 |
|
|
|
|
|
|
|
| EP3 antagonist 3 |
|
|
|
|
|
|
99.52% |
| EP3 antagonist 4 |
|
|
|
|
|
|
|
| EP3 antagonist 5 |
|
|
|
|
|
|
|
| EP3 antagonist 6 |
|
|
|
|
|
|
|
| EP3 antagonist 7 |
|
|
|
|
|
|
|
| EP4 receptor agonist 1 |
|
|
|
|
|
|
|
| EP4 receptor agonist 2 |
|
|
|
|
|
|
99.0% |
| EP4 receptor agonist 3 |
|
|
|
|
|
|
|
| EP4 receptor antagonist 1 |
|
|
|
|
|
|
99.94% |
| EP4 receptor antagonist 2 |
|
|
|
|
|
|
99.01% |
| EP4 receptor antagonist 5 |
|
|
|
|
|
|
|
| EP4 receptor antagonist 7 |
|
|
|
|
|
|
99.9% |
| EP4 receptor antagonist 8 |
|
|
|
|
|
|
|
| EP4-IN-1 |
|
|
|
|
|
|
99.94% |
| ER-819762 |
|
|
|
|
|
|
|
| Etofylline clofibrate |
|
|
|
|
|
|
99.77% |
| Evatanepag |
|
|
|
|
|
|
98.58% |
| Evatanepag sodium |
|
|
|
|
|
|
|
| FCE 20700 |
|
|
|
|
|
|
|
| FK-788 |
|
|
|
|
|
|
|
| Flunoprost |
|
|
|
|
|
|
|
| Fluprostenol methyl ester |
|
|
|
|
|
|
|
| FR-181877 |
|
|
|
|
|
|
|
| FR181157 |
|
|
|
|
|
|
|
| FR191413 |
|
|
|
|
|
|
|
| Furegrelate |
|
|
|
|
|
|
|
| Furegrelate sodium |
|
|
|
|
|
|
99.69% |
| Grapiprant |
|
|
|
|
|
|
99.57% |
| Grapiprant-d4 |
|
|
|
|
|
|
|
| GSK-269984A |
|
|
|
|
|
|
99.58% |
| GSK-269984B |
|
|
|
|
|
|
|
| GSK345931A |
|
|
|
|
|
|
|
| GSK726701A |
|
|
|
|
|
|
98.27% |
| GW 848687X |
|
|
|
|
|
|
|
| GW627368 |
|
|
|
|
|
|
99.95% |
| HHS-0701 |
|
|
|
|
|
|
98.90% |
| HTL0039732 |
|
|
|
|
|
|
99.29% |
| I-BOP |
|
|
|
|
|
|
|
| I-SAP |
|
|
|
|
|
|
|
| Ibuprofen guaiacol ester |
|
|
|
|
|
|
98.16% |
| ICI 185282 |
|
|
|
|
|
|
|
| ICI 192605 |
|
|
|
|
|
|
|
| ICI D1542 |
|
|
|
|
|
|
|
| Ifetroban sodium |
|
|
|
|
|
|
99.83% |
| Imitrodast |
|
|
|
|
|
|
|
| Imitrodast sodium |
|
|
|
|
|
|
|
| IP receptor agonist 1 |
|
|
|
|
|
|
|
| IP receptor antagonist 1 |
|
|
|
|
|
|
|
| Irodanoprost |
|
|
|
|
|
|
|
| Isbogrel |
|
|
|
|
|
|
|
| iso-Samixogrel |
|
|
|
|
|
|
|
| Isopropyl 5-(diphenylphosphoryl)pentanoate |
|
|
|
|
|
|
|
| JAK05 |
|
|
|
|
|
|
|
| Kaempferol 3-O-(2G-glucosylrutinoside)-7-O-glucoside |
|
|
|
|
|
|
|
| KAG-308 |
|
|
|
|
|
|
98.62% |
| KC-764 |
|
|
|
|
|
|
|
| KF 13218 |
|
|
|
|
|
|
|
| KF15766 |
|
|
|
|
|
|
|
| KP496 |
|
|
|
|
|
|
99.79% |
| KT2-962 |
|
|
|
|
|
|
|
| KW-8232 |
|
|
|
|
|
|
98.10% |
| KW-8232 free base |
|
|
|
|
|
|
95.0% |
| L 377202 |
|
|
|
|
|
|
|
| L 640035 |
|
|
|
|
|
|
|
| L 655240 |
|
|
|
|
|
|
|
| L 657925 |
|
|
|
|
|
|
|
| L 888607 |
|
|
|
|
|
|
99.87% |
| L 888607 Racemate |
|
|
|
|
|
|
99.81% |
| L-10503 |
|
|
|
|
|
|
|
| L-161982 |
|
|
|
|
|
|
99.33% |
| L-641953 |
|
|
|
|
|
|
|
| L-644698 |
|
|
|
|
|
|
|
| L-657926 |
|
|
|
|
|
|
|
| L-670596 |
|
|
|
|
|
|
|
| L-798106 |
|
|
|
|
|
|
99.91% |
| L-826266 |
|
|
|
|
|
|
99.70% |
| L-902688 |
|
|
|
|
|
|
99.0% |
| L11204 |
|
|
|
|
|
|
|
| Laflunimus |
|
|
|
|
|
|
99.70% |
| Laropiprant sodium |
|
|
|
|
|
|
|
| LAS191859 |
|
|
|
|
|
|
99.93% |
| Latanoprost acid |
|
|
|
|
|
|
98.77% |
| Latanoprost amide |
|
|
|
|
|
|
|
| Latanoprost ethyl amide |
|
|
|
|
|
|
|
| Latanoprost ethyl amide-d4 |
|
|
|
|
|
|
|
| Latanoprost tris(triethylsilyl) ether |
|
|
|
|
|
|
|
| Latanoprostene bunod |
|
|
|
|
|
|
99.75% |
| LCB 2853 sodium |
|
|
|
|
|
|
|
| LCB-2853 |
|
|
|
|
|
|
|
| LG 82-4-00 |
|
|
|
|
|
|
|
| LG 82-4-01 |
|
|
|
|
|
|
|
| Linotroban |
|
|
|
|
|
|
95.07% |
| Lythrine |
|
|
|
|
|
|
|
| MB-28767 |
|
|
|
|
|
|
|
| MDL 19301 |
|
|
|
|
|
|
|
| MED 27 |
|
|
|
|
|
|
|
| Meteneprost |
|
|
|
|
|
|
|
| Meteneprost potassium |
|
|
|
|
|
|
|
| MF-592 |
|
|
|
|
|
|
|
| MF-766 |
|
|
|
|
|
|
99.83% |
| MF266-1 |
|
|
|
|
|
|
|
| MF498 |
|
|
|
|
|
|
99.26% |
| MF498 (Standard) |
|
|
|
|
|
|
|
| MK-1029 |
|
|
|
|
|
|
|
| MK-2894 |
|
|
|
|
|
|
99.31% |
| MK-2894 sodium salt |
|
|
|
|
|
|
|
| MK-447 |
|
|
|
|
|
|
|
| MK-7246 |
|
|
|
|
|
|
99.63% |
| MK-7246 S enantiomer |
|
|
|
|
|
|
|
| MK-8318 |
|
|
|
|
|
|
|
| mPGES-1/sEH-IN-1 |
|
|
|
|
|
|
|
| MRE-269 |
|
|
|
|
|
|
99.14% |
| MRE-269-d6 |
|
|
|
|
|
|
|
| MRE-269-d7 |
|
|
|
|
|
|
99.59% |
| MRE-269-d7 sodium |
|
|
|
|
|
|
|
| MTPPA |
|
|
|
|
|
|
99.82% |
| N-Cyclopropyl bimatoprost |
|
|
|
|
|
|
|
| N-Cyclopropyl methyl bimatoprost |
|
|
|
|
|
|
|
| N1-Acetyl-5-methoxykynuramine hydrochloride |
|
|
|
|
|
|
|
| Nafagrel hydrochloride |
|
|
|
|
|
|
|
| Naxaprostene |
|
|
|
|
|
|
|
| ND-7001 |
|
|
|
|
|
|
|
| Nedocromil sodium |
|
|
|
|
|
|
|
| Nileprost |
|
|
|
|
|
|
|
| Nocistatin(human) |
|
|
|
|
|
|
|
| Nocistatin(human) TFA |
|
|
|
|
|
|
|
| NP-1815-PX |
|
|
|
|
|
|
|
| NP-1815-PX sodium |
|
|
|
|
|
|
99.51% |
| NP-184 |
|
|
|
|
|
|
|
| NTP42 |
|
|
|
|
|
|
98.58% |
| NVP-QAV680 |
|
|
|
|
|
|
|
| NXT-10796 |
|
|
|
|
|
|
|
| O-Acetylsalicylhydroxamic acid |
|
|
|
|
|
|
|
| O-Desmethyl-N-deschlorobenzoyl Indomethacin |
|
|
|
|
|
|
|
| Omidenepag |
|
|
|
|
|
|
99.86% |
| Omidenepag isopropyl |
|
|
|
|
|
|
98.17% |
| ONO 1301 |
|
|
|
|
|
|
99.02% |
| ONO 1301 (Standard) |
|
|
|
|
|
|
|
| ONO 207 |
|
|
|
|
|
|
|
| ONO 3708 |
|
|
|
|
|
|
|
| ONO-8130 |
|
|
|
|
|
|
|
| ONO-8539 |
|
|
|
|
|
|
|
| ONO-8711 |
|
|
|
|
|
|
|
| ONO-8711 dicyclohexylamine |
|
|
|
|
|
|
99.30% |
| ONO-8713 |
|
|
|
|
|
|
99.0% |
| ONO-8815Ly |
|
|
|
|
|
|
|
| ONO-AE 248 |
|
|
|
|
|
|
98.27% |
| ONO-AE3-208 |
|
|
|
|
|
|
98.97% |
| ONO-AE3-208 sodium salt |
|
|
|
|
|
|
|
| OP-2507 |
|
|
|
|
|
|
|
| Ozagrel hydrochloride |
|
|
|
|
|
|
99.86% |
| Ozagrel hydrochloride (Standard) |
|
|
|
|
|
|
98% |
| p-Hydroxycinnamic acid |
|
|
|
|
|
|
99.94% |
| Palupiprant |
|
|
|
|
|
|
99.96% |
| PDC31 |
|
|
|
|
|
|
98.67% |
| Pexopiprant |
|
|
|
|
|
|
99.40% |
| PF-04418948 |
|
|
|
|
|
|
99.40% |
| PF-04475270 |
|
|
|
|
|
|
|
| PGD2-IN-1 |
|
|
|
|
|
|
98.03% |
| PGDM |
|
|
|
|
|
|
|
| PGF2α analogue-1 |
|
|
|
|
|
|
|
| PGF2α-isopropyl ester |
|
|
|
|
|
|
|
| PGN-9856 |
|
|
|
|
|
|
98.90% |
| Picotamide |
|
|
|
|
|
|
99.76% |
| Picotamide monohydrate |
|
|
|
|
|
|
|
| Pimilprost |
|
|
|
|
|
|
|
| Pizuglanstat |
|
|
|
|
|
|
99.70% |
| Pizuglanstat hydrate |
|
|
|
|
|
|
|
| Prostaglandin A1 methyl ester |
|
|
|
|
|
|
|
| Prostaglandin A2 methyl ester |
|
|
|
|
|
|
|
| Prostaglandin A3 |
|
|
|
|
|
|
|
| Prostaglandin D1 alcohol |
|
|
|
|
|
|
|
| Prostaglandin D2 |
|
|
|
|
|
|
99.5% |
| Prostaglandin D2 methyl ester |
|
|
|
|
|
|
97.1% |
| Prostaglandin D2 serinol amide |
|
|
|
|
|
|
|
| Prostaglandin D2-1-glyceryl ester |
|
|
|
|
|
|
|
| Prostaglandin D2-d4 |
|
|
|
|
|
|
98.81% |
| Prostaglandin D2-d9 |
|
|
|
|
|
|
99.0% |
| Prostaglandin D3 |
|
|
|
|
|
|
|
| Prostaglandin E1 alcohol |
|
|
|
|
|
|
|
| Prostaglandin E1 ethanolamide |
|
|
|
|
|
|
|
| Prostaglandin E1 ethyl ester |
|
|
|
|
|
|
|
| Prostaglandin E1 isopropyl ester |
|
|
|
|
|
|
|
| Prostaglandin E2 Ethanolamide |
|
|
|
|
|
|
|
| Prostaglandin E2 isopropyl ester |
|
|
|
|
|
|
|
| Prostaglandin E2 serinol amide |
|
|
|
|
|
|
|
| Prostaglandin E3 |
|
|
|
|
|
|
98.4% |
| Prostaglandin F1a |
|
|
|
|
|
|
98.10% |
| Prostaglandin F1a-d9 |
|
|
|
|
|
|
|
| Prostaglandin F1β |
|
|
|
|
|
|
|
| Prostaglandin F2a/BSA |
|
|
|
|
|
|
|
| Prostaglandin F2α 1,11-lactone |
|
|
|
|
|
|
|
| Prostaglandin F2α alcohol |
|
|
|
|
|
|
|
| Prostaglandin F2α alcohol methyl ether |
|
|
|
|
|
|
|
| Prostaglandin F2α dimethyl amide |
|
|
|
|
|
|
|
| Prostaglandin F2α dimethyl amine |
|
|
|
|
|
|
|
| Prostaglandin F2α ethanolamide |
|
|
|
|
|
|
98.2% |
| Prostaglandin F2α ethyl amide |
|
|
|
|
|
|
|
| Prostaglandin F2α methyl ester |
|
|
|
|
|
|
|
| Prostaglandin F2α serinol amide |
|
|
|
|
|
|
99.41% |
| Prostaglandin F2α-biotin |
|
|
|
|
|
|
|
| Prostaglandin K1 |
|
|
|
|
|
|
|
| Prostaglandin K2 |
|
|
|
|
|
|
|
| PROTAC(H-PGDS)-7 |
|
|
|
|
|
|
99.42% |
| PROTAC(H-PGDS)-8 |
|
|
|
|
|
|
|
| PSA1 (141-150) |
|
|
|
|
|
|
|
| QCC374 |
|
|
|
|
|
|
|
| Ralinepag |
|
|
|
|
|
|
99.27% |
| rel-Latanoprost acid |
|
|
|
|
|
|
|
| Ridogrel |
|
|
|
|
|
|
99.28% |
| Rioprostil |
|
|
|
|
|
|
|
| Rivenprost |
|
|
|
|
|
|
99.0% |
| RJG-2036 |
|
|
|
|
|
|
|
| Ro 22-3581 |
|
|
|
|
|
|
99.91% |
| Ro 22-9194 |
|
|
|
|
|
|
|
| Ro 23-3423 |
|
|
|
|
|
|
|
| RO1138452 |
|
|
|
|
|
|
99.26% |
| RO3244794 |
|
|
|
|
|
|
99.64% |
| Rolafagrel |
|
|
|
|
|
|
|
| RS 93427-007 |
|
|
|
|
|
|
|
| RS-601 |
|
|
|
|
|
|
|
| RS-61756-007 |
|
|
|
|
|
|
|
| RU 59063 |
|
|
|
|
|
|
98.61% |
| S-5751 |
|
|
|
|
|
|
|
| Salviifoside A |
|
|
|
|
|
|
|
| Samixogrel |
|
|
|
|
|
|
|
| Satigrel |
|
|
|
|
|
|
99.85% |
| SC 34301 |
|
|
|
|
|
|
|
| SC 51089 |
|
|
|
|
|
|
|
| SC 51089 free base |
|
|
|
|
|
|
98.60% |
| SC-19220 |
|
|
|
|
|
|
99.86% |
| SC-19220 (Standard) |
|
|
|
|
|
|
|
| SC-42867 |
|
|
|
|
|
|
|
| SC-51322 |
|
|
|
|
|
|
98.93% |
| Selexipag |
|
|
|
|
|
|
99.86% |
| Selexipag-d6 |
|
|
|
|
|
|
|
| Selexipag-d7 |
|
|
|
|
|
|
98.44% |
| Sepetaprost |
|
|
|
|
|
|
|
| Spizofurone |
|
|
|
|
|
|
|
| SQ 26655 |
|
|
|
|
|
|
|
| SQ 29548 |
|
|
|
|
|
|
99.9% |
| SQ-30741 |
|
|
|
|
|
|
|
| ST026567 |
|
|
|
|
|
|
|
| Sulotroban |
|
|
|
|
|
|
99.29% |
| SZ0232 |
|
|
|
|
|
|
99.25% |
| T26A |
|
|
|
|
|
|
|
| Tafluprost acid |
|
|
|
|
|
|
99.80% |
| Tafluprost ethyl ester |
|
|
|
|
|
|
|
| Taprenepag |
|
|
|
|
|
|
98.79% |
| Taprenepag isopropyl |
|
|
|
|
|
|
99.02% |
| Taprostene |
|
|
|
|
|
|
|
| Taprostene sodium |
|
|
|
|
|
|
|
| TASP0376377 |
|
|
|
|
|
|
|
| TASP0412098 |
|
|
|
|
|
|
|
| TCS 2510 |
|
|
|
|
|
|
98.30% |
| Teopranitol |
|
|
|
|
|
|
|
| Terutroban |
|
|
|
|
|
|
99.84% |
| Terutroban sodium |
|
|
|
|
|
|
98.49% |
| Tetranor-PGDM |
|
|
|
|
|
|
|
| Tetranor-PGDM-d6 |
|
|
|
|
|
|
|
| tetranor-PGFM |
|
|
|
|
|
|
|
| tetranor-Prostaglandin E1 |
|
|
|
|
|
|
|
| TG11-77 hydrochloride |
|
|
|
|
|
|
|
| TG4-155 |
|
|
|
|
|
|
99.91% |
| TG6-10-1 |
|
|
|
|
|
|
99.50% |
| TG6-129 |
|
|
|
|
|
|
|
| TG8-260 |
|
|
|
|
|
|
99.13% |
| TGI-15 |
|
|
|
|
|
|
|
| Thielavin A |
|
|
|
|
|
|
96.47% |
| Thielavin B |
|
|
|
|
|
|
|
| Tiaprost |
|
|
|
|
|
|
98.0% |
| Timapiprant |
|
|
|
|
|
|
98.03% |
| Timapiprant sodium |
|
|
|
|
|
|
98.71% |
| Topo I/COX-2-IN-1 |
|
|
|
|
|
|
|
| TP receptor antagonist-1 |
|
|
|
|
|
|
|
| TP receptor antagonist-2 |
|
|
|
|
|
|
|
| TP receptor antagonist-3 |
|
|
|
|
|
|
99.88% |
| TP-16 |
|
|
|
|
|
|
|
| TPα/β antagonist-1 |
|
|
|
|
|
|
|
| trans-Isoferulic acid |
|
|
|
|
|
|
99.93% |
| trans-Isoferulic acid-d3 |
|
|
|
|
|
|
|
| trans-Latanoprost |
|
|
|
|
|
|
98.35% |
| trans-Latanoprost acid |
|
|
|
|
|
|
|
| Treprostinil palmitil |
|
|
|
|
|
|
99.62% |
| Treprostinil-d7 |
|
|
|
|
|
|
|
| U-44069 |
|
|
|
|
|
|
98.0% |
| U-44069 serinol amide |
|
|
|
|
|
|
|
| U-46619 |
|
|
|
|
|
|
99.61% |
| U-46619 Glycine methyl ester |
|
|
|
|
|
|
|
| U-46619 serinol amide |
|
|
|
|
|
|
|
| UK 34787 |
|
|
|
|
|
|
|
| Vapiprost |
|
|
|
|
|
|
|
| Vapiprost hydrochloride |
|
|
|
|
|
|
|
| Vidupiprant |
|
|
|
|
|
|
98.31% |
| Vorbipiprant |
|
|
|
|
|
|
98.89% |
| Wy 27569 |
|
|
|
|
|
|
|
| Y-20811 sodium |
|
|
|
|
|
|
|
| YM158 free base |
|
|
|
|
|
|
|
| Z-335 sodium |
|
|
|
|
|
|
|
| ZK118182 Isopropyl ester |
|
|
|
|
|
|
|
| ZPL-5212372 |
|
|
|
|
|
|
|
| Δ17-6-keto Prostaglandin F1α |
|
|
|
|
|
|
|
| Δ7-Avenasterol |
|
|
|
|
|
|
95.0% |
| Triflusal |
|
|
|
|
|
|
99.56% |
| Triflusal-d3 |
|
|
|
|
|
|
|
| Proquinazid |
|
|
|
|
|
|
|
| Prostate specific antigen protein (human) |
|
|
|
|
|
|
95.00% |
| Ginsenoside Ro |
|
|
|
|
|
|
99.81% |
| Tafluprost |
|
|
|
|
|
|
99.69% |
| Iloprost-d4 |
|
|
|
|
|
|
|
| Iloprost |
|
|
|
|
|
|
98.32% |
| Ifetroban |
|
|
|
|
|
|
99.65% |
| Etersalate |
|
|
|
|
|
|
|
| Prostaglandin E1 (Standard) |
|
|
|
|
|
|
98% |
| Prostaglandin E1-d4 |
|
|
|
|
|
|
|
| Prostaglandin E1-d9 |
|
|
|
|
|
|
|
| Prostaglandin E1 |
|
|
|
|
|
|
99.76% |
| Prostaglandin E2-d4 |
|
|
|
|
|
|
99.9% |
| Prostaglandin E2-d9 |
|
|
|
|
|
|
|
| Prostaglandin E2 (Standard) |
|
|
|
|
|
|
99.81% |
| Prostaglandin E2 |
|
|
|
|
|
|
99.64% |
| PGF2α 1,9-lactone |
|
|
|
|
|
|
|
| Prostaglandin J2 |
|
|
|
|
|
|
98.1% |
| 8-iso Prostaglandin E1 |
|
|
|
|
|
|
|
| Carboprost |
|
|
|
|
|
|
99.84% |
| Carbacyclin |
|
|
|
|
|
|
98.01% |
| Seprilose |
|
|
|
|
|
|
|
| Gemeprost |
|
|
|
|
|
|
|
| Amtolmetin guacil |
|
|
|
|
|
|
99.93% |
| Guacetisal |
|
|
|
|
|
|
98.87% |
| Dazoxiben |
|
|
|
|
|
|
|
| Zoliprofen |
|
|
|
|
|
|
|
| Quinotolast sodium |
|
|
|
|
|
|
98.38% |
| Dinoprost-d4 |
|
|
|
|
|
|
99.9% |
| Dinoprost-d9 |
|
|
|
|
|
|
|
| Dinoprost-13C5 |
|
|
|
|
|
|
|
| Dinoprost |
|
|
|
|
|
|
99.84% |
| Dinoprost tromethamine salt |
|
|
|
|
|
|
98.0% |
| Seratrodast |
|
|
|
|
|
|
99.59% |
| Setipiprant |
|
|
|
|
|
|
98.23% |
| Canniprene |
|
|
|
|
|
|
98.0% |
| Cefminox sodium |
|
|
|
|
|
|
99.83% |
| Nedocromil |
|
|
|
|
|
|
98.19% |
| Nepafenac |
|
|
|
|
|
|
99.56% |
| Nepafenac-d5 |
|
|
|
|
|
|
98.84% |
| Ozagrel |
|
|
|
|
|
|
99.81% |
| Ozagrel sodium |
|
|
|
|
|
|
99.82% |
| Droxicam |
|
|
|
|
|
|
99.59% |
| Cornuside |
|
|
|
|
|
|
99.99% |
| Bunaprolast |
|
|
|
|
|
|
|
| Latanoprost-d4 |
|
|
|
|
|
|
98.0% |
| Latanoprost (Standard) |
|
|
|
|
|
|
98% |
| Latanoprost |
|
|
|
|
|
|
99.85% |
| Laropiprant |
|
|
|
|
|
|
99.34% |
| Travoprost (Standard) |
|
|
|
|
|
|
98% |
| Travoprost-d7 |
|
|
|
|
|
|
|
| Travoprost |
|
|
|
|
|
|
99.79% |
| Treprostinil diethanolamine |
|
|
|
|
|
|
99.44% |
| Treprostinil sodium |
|
|
|
|
|
|
99.55% |
| Treprostinil-13C2,d1 Sodium |
|
|
|
|
|
|
|
| Treprostinil-13C2,d |
|
|
|
|
|
|
|
| Treprostinil |
|
|
|
|
|
|
99.95% |
| Trapidil |
|
|
|
|
|
|
98.0% |
| Tranilast |
|
|
|
|
|
|
99.95% |
| Tranilast sodium |
|
|
|
|
|
|
99.48% |
| Coniferin |
|
|
|
|
|
|
98.84% |
| Pectolinarin |
|
|
|
|
|
|
99.89% |
| Bimatoprost |
|
|
|
|
|
|
99.98% |
| Bimatoprost-d4 |
|
|
|
|
|
|
|
| Bimatoprost-d5 |
|
|
|
|
|
|
98.24% |
| 17-Phenyl trinor prostaglandin F2α methyl amide |
|
|
|
|
|
|
|
| Froxiprost |
|
|
|
|
|
|
|
| Ufenamate |
|
|
|
|
|
|
99.89% |
| Cloprostenol sodium salt |
|
|
|
|
|
|
99.84% |
| Cloprostenol |
|
|
|
|
|
|
99.86% |
| Cyanidin Chloride |
|
|
|
|
|
|
99.43% |
| Losmiprofen |
|
|
|
|
|
|
|
| Lornoxicam |
|
|
|
|
|
|
99.36% |
| Serratiopeptidase |
|
|
|
|
|
|
|
| Alclofenac |
|
|
|
|
|
|
99.44% |
| Alclofenac sodium |
|
|
|
|
|
|
|
| Terbogrel |
|
|
|
|
|
|
|
| Rebamipide-d4 |
|
|
|
|
|
|
99.0% |
| Darbufelone mesylate |
|
|
|
|
|
|
99.65% |
| Saikogenin D |
|
|
|
|
|
|
99.99% |
| Sulprostone |
|
|
|
|
|
|
95.01% |
| Chondroitin sulfate (from chicken) |
|
|
|
|
|
|
99.61% |
| Chikusetsusaponin IVa methyl ester |
|
|
|
|
|
|
|
| Misoprostol acid |
|
|
|
|
|
|
99.0% |
| Misoprostol acid-d5 |
|
|
|
|
|
|
|
| Dehydroandrographolide succinate |
|
|
|
|
|
|
99.34% |
| Ricinoleic acid (purity≥85%) |
|
|
|
|
|
|
85.0% |
| Ricinoleic acid (purity≥99%) |
|
|
|
|
|
|
99.93% |
| Thromboxane B2 |
|
|
|
|
|
|
99.0% |
| Thromboxane B2-d9 |
|
|
|
|
|
|
|
| Epi-cryptoacetalide |
|
|
|
|
|
|
|
| Epibetulinic acid |
|
|
|
|
|
|
98.0% |
| Epibetulinic acid-d3 |
|
|
|
|
|
|
|
| Nocloprost |
|
|
|
|
|
|
|
| (Rac)-Beraprost sodium |
|
|
|
|
|
|
99.0% |
| Beraprost sodium |
|
|
|
|
|
|
98.34% |
| Benorilate |
|
|
|
|
|
|
99.47% |
| Octimibate |
|
|
|
|
|
|
|
| Dazoxiben hydrochloride |
|
|
|
|
|
|
99.90% |
| Darbufelone |
|
|
|
|
|
|
98.0% |
| Ethamsylate |
|
|
|
|
|
|
99.49% |
| Licarin A |
|
|
|
|
|
|
99.83% |
| Anitrazafen |
|
|
|
|
|
|
|
| Ramatroban |
|
|
|
|
|
|
99.23% |
| Ramatroban-d4 |
|
|
|
|
|
|
|
| Fevipiprant |
|
|
|
|
|
|
99.38% |